There is no medical discipline where treatment and treatment selection is as dynamic as in acute ischemic stroke. However, the introduction of these novel treatments are accompanied with high costs due to validation stages in clinical trials. In INSIST we develop an in silico alternative where disease and treatment is captures in computer models such that whole clinical trials can be simulated. This also involved data-driven AI modeling
Computers in Biology and Medicine, 115 , 2019.